These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 23423742

  • 1. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.
    Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B.
    J Clin Oncol; 2013 Apr 01; 31(10):1302-9. PubMed ID: 23423742
    [Abstract] [Full Text] [Related]

  • 2. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
    Kasiske BL, Kukla A, Thomas D, Wood Ives J, Snyder JJ, Qiu Y, Peng Y, Dharnidharka VR, Israni AK.
    Am J Kidney Dis; 2011 Dec 01; 58(6):971-80. PubMed ID: 21930332
    [Abstract] [Full Text] [Related]

  • 3. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.
    Ghobrial IM, Habermann TM, Maurer MJ, Geyer SM, Ristow KM, Larson TS, Walker RC, Ansell SM, Macon WR, Gores GG, Stegall MD, McGregor CG.
    J Clin Oncol; 2005 Oct 20; 23(30):7574-82. PubMed ID: 16186599
    [Abstract] [Full Text] [Related]

  • 4. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 20; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 5. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ, Homan van der Heide JJ, Veeger NJ, Kluin PM, Kluin-Nelemans HC.
    Clin Transplant; 2005 Jun 20; 19(3):327-34. PubMed ID: 15877793
    [Abstract] [Full Text] [Related]

  • 6. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.
    Caillard S, Lelong C, Pessione F, Moulin B, French PTLD Working Group.
    Am J Transplant; 2006 Nov 20; 6(11):2735-42. PubMed ID: 17049061
    [Abstract] [Full Text] [Related]

  • 7. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
    Rabot N, Büchler M, Foucher Y, Moreau A, Debiais C, Machet MC, Kessler M, Morelon E, Thierry A, Legendre C, Rivalan J, Kamar N, Dantal J.
    Transpl Int; 2014 Sep 20; 27(9):956-65. PubMed ID: 24964147
    [Abstract] [Full Text] [Related]

  • 8. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV.
    Nephrol Dial Transplant; 2012 Jul 20; 27(7):2971-9. PubMed ID: 22273720
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas.
    Caillard S, Lamy FX, Quelen C, Dantal J, Lebranchu Y, Lang P, Velten M, Moulin B, French Transplant Centers.
    Am J Transplant; 2012 Mar 20; 12(3):682-93. PubMed ID: 22226336
    [Abstract] [Full Text] [Related]

  • 10. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M, Marciano S, dos Santos Schraiber L, Zapata R, Quiros R, Zanotelli ML, Rivas MM, Kusminsky G, Humeres R, Alves de Mattos A, Gadano A, Silva MO.
    Clin Transplant; 2013 Mar 20; 27(4):E469-77. PubMed ID: 23758407
    [Abstract] [Full Text] [Related]

  • 11. Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group.
    Caillard S, Lachat V, Moulin B.
    Transpl Int; 2000 Mar 20; 13 Suppl 1():S388-93. PubMed ID: 11112039
    [Abstract] [Full Text] [Related]

  • 12. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    OʼRegan JA, Prendeville S, McCaughan JA, Traynor C, OʼBrien FJ, Ward FL, OʼDonovan D, Kennedy C, Berzan E, Kinsella S, Williams Y, OʼKelly P, Deady S, Comber H, Leader M, Conlon PJ.
    Transplantation; 2017 Mar 20; 101(3):657-663. PubMed ID: 27214265
    [Abstract] [Full Text] [Related]

  • 13. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube GF, Müller-Wiefel DE, Netz H, Pohl M, Toenshoff B, Wagner HJ, Wallot M, Welte K, Melter M, Offner G, Klein C.
    J Clin Oncol; 2007 Nov 01; 25(31):4902-8. PubMed ID: 17971586
    [Abstract] [Full Text] [Related]

  • 14. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
    Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW.
    Transplantation; 2003 Nov 15; 76(9):1289-93. PubMed ID: 14627905
    [Abstract] [Full Text] [Related]

  • 15. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study.
    Francis A, Johnson DW, Teixeira-Pinto A, Craig JC, Wong G.
    Nephrol Dial Transplant; 2018 May 01; 33(5):881-889. PubMed ID: 29342279
    [Abstract] [Full Text] [Related]

  • 16. Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - a national study.
    Cleper R, Ben Shalom E, Landau D, Weissman I, Krause I, Konen O, Rahamimov R, Mor E, Bar-Nathan N, Frishberg Y, Davidovits M.
    Pediatr Transplant; 2012 Sep 01; 16(6):619-26. PubMed ID: 22708682
    [Abstract] [Full Text] [Related]

  • 17. Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.
    Maksten EF, Vase MØ, Kampmann J, d'Amore F, Møller MB, Strandhave C, Bendix K, Bistrup C, Thiesson HC, Søndergaard E, Hamilton-Dutoit S, Jespersen B.
    Transpl Int; 2016 Apr 01; 29(4):483-93. PubMed ID: 26749337
    [Abstract] [Full Text] [Related]

  • 18. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases.
    Tiede C, Maecker-Kolhoff B, Klein C, Kreipe H, Hussein K.
    Transplantation; 2013 Feb 15; 95(3):479-88. PubMed ID: 23296147
    [Abstract] [Full Text] [Related]

  • 19. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
    Khedmat H, Taheri S.
    Ann Transplant; 2010 Feb 15; 15(3):80-6. PubMed ID: 20877272
    [Abstract] [Full Text] [Related]

  • 20. [Lymphoproliferative disorders in kidney transplant recipients: incidence, clinical characteristics and outcome].
    Abderrahim E, Harzallah A, Barbouch S, Turki S, Helal I, Ben Abdallah T, Hedri H, Ben Moussa F, Bardi R, Ayed K, Ben Maïz H, Kheder A.
    Rev Med Interne; 2008 Jul 15; 29(7):535-40. PubMed ID: 18262684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.